• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于[镓]镓-PSMA-11 PET和MRI-ADC对前列腺癌国际泌尿病理学会(ISUP)分级进行预测的影像组学分析:BIOPSTAGE试验的初步结果

Radiomics Analysis on [Ga]Ga-PSMA-11 PET and MRI-ADC for the Prediction of Prostate Cancer ISUP Grades: Preliminary Results of the BIOPSTAGE Trial.

作者信息

Feliciani Giacomo, Celli Monica, Ferroni Fabio, Menghi Enrico, Azzali Irene, Caroli Paola, Matteucci Federica, Barone Domenico, Paganelli Giovanni, Sarnelli Anna

机构信息

Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.

Nuclear Medicine and Radiometabolic Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.

出版信息

Cancers (Basel). 2022 Apr 8;14(8):1888. doi: 10.3390/cancers14081888.

DOI:10.3390/cancers14081888
PMID:35454793
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9028386/
Abstract

Prostate cancer (PCa) risk categorization based on clinical/PSA testing results in a substantial number of men being overdiagnosed with indolent, early-stage PCa. Clinically non-significant PCa is characterized as the presence of ISUP grade one, where PCa is found in no more than two prostate biopsy cores.MRI-ADC and [Ga]Ga-PSMA-11 PET have been proposed as tools to predict ISUP grade one patients and consequently reduce overdiagnosis. In this study, Radiomics analysis is applied to MRI-ADC and [Ga]Ga-PSMA-11 PET maps to quantify tumor characteristics and predict histology-proven ISUP grades. ICC was applied with a threshold of 0.6 to assess the features' stability with variations in contouring. Logistic regression predictive models based on imaging features were trained on 31 lesions to differentiate ISUP grade one patients from ISUP two+ patients. The best model based on [Ga]Ga-PSMA-11 PET returned a prediction efficiency of 95% in the training phase and 100% in the test phase whereas the best model based on MRI-ADC had an efficiency of 100% in both phases. Employing both imaging modalities, prediction efficiency was 100% in the training phase and 93% in the test phase. Although our patient cohort was small, it was possible to assess that both imaging modalities add information to the prediction models and show promising results for further investigations.

摘要

基于临床/前列腺特异抗原(PSA)检测结果对前列腺癌(PCa)进行风险分类,导致大量男性被过度诊断为惰性早期PCa。临床意义不显著的PCa的特征是国际泌尿病理学会(ISUP)1级,即在不超过两个前列腺活检组织芯中发现PCa。磁共振成像表观扩散系数(MRI-ADC)和镓[Ga]镓前列腺特异性膜抗原(PSMA)-11正电子发射断层显像(PET)已被提议作为预测ISUP 1级患者从而减少过度诊断的工具。在本研究中,将影像组学分析应用于MRI-ADC和[Ga]Ga-PSMA-11 PET图像,以量化肿瘤特征并预测经组织学证实的ISUP分级。应用组内相关系数(ICC),阈值为0.6,以评估特征在轮廓变化时的稳定性。基于影像特征的逻辑回归预测模型在31个病灶上进行训练,以区分ISUP 1级患者和ISUP 2级及以上患者。基于[Ga]Ga-PSMA-11 PET的最佳模型在训练阶段的预测效率为95%,在测试阶段为100%;而基于MRI-ADC的最佳模型在两个阶段的效率均为100%。采用两种成像方式时,训练阶段的预测效率为100%,测试阶段为93%。尽管我们的患者队列规模较小,但可以评估这两种成像方式都为预测模型增加了信息,并显示出进一步研究的良好前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a175/9028386/069e7ef6ee09/cancers-14-01888-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a175/9028386/3e01e1370889/cancers-14-01888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a175/9028386/54b7c3e32439/cancers-14-01888-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a175/9028386/069e7ef6ee09/cancers-14-01888-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a175/9028386/3e01e1370889/cancers-14-01888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a175/9028386/54b7c3e32439/cancers-14-01888-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a175/9028386/069e7ef6ee09/cancers-14-01888-g003.jpg

相似文献

1
Radiomics Analysis on [Ga]Ga-PSMA-11 PET and MRI-ADC for the Prediction of Prostate Cancer ISUP Grades: Preliminary Results of the BIOPSTAGE Trial.基于[镓]镓-PSMA-11 PET和MRI-ADC对前列腺癌国际泌尿病理学会(ISUP)分级进行预测的影像组学分析:BIOPSTAGE试验的初步结果
Cancers (Basel). 2022 Apr 8;14(8):1888. doi: 10.3390/cancers14081888.
2
The added value of PSMA PET/MR radiomics for prostate cancer staging.PSMA PET/MR 放射组学在前列腺癌分期中的附加价值。
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):527-538. doi: 10.1007/s00259-021-05430-z. Epub 2021 Jul 13.
3
Role of [Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer.[Ga]Ga-PSMA-11 PET 放射组学预测原发性前列腺癌术后 ISUP 分级的作用。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2548-2560. doi: 10.1007/s00259-023-06187-3. Epub 2023 Mar 18.
4
Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer.镓-PSMA PET/CT 用于高危前列腺癌的原发淋巴结和远处转移 NM 分期。
J Nucl Med. 2021 Feb;62(2):214-220. doi: 10.2967/jnumed.120.245605. Epub 2020 May 22.
5
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
6
Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.术前 3-T 多参数 MRI 和 Ga-PSMA PET/CT 扫描对前列腺癌根治性前列腺切除术和盆腔淋巴结清扫术病理结果的预测价值的组织学比较。
BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7.
7
Diagnostic accuracy of Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of Ga-PSMA PET to mpMRI.使用全层病理检测前列腺中级前列腺癌时,镓标记前列腺特异性膜抗原(PSMA)正电子发射断层扫描(PET)和多参数(mp)MRI的诊断准确性:在mpMRI中添加镓标记PSMA PET的影响
BJU Int. 2019 Nov;124 Suppl 1:42-49. doi: 10.1111/bju.14794. Epub 2019 Jul 9.
8
Diagnostic value of integrated F-PSMA-1007 PET/MRI compared with that of biparametric MRI for the detection of prostate cancer.集成F-PSMA-1007 PET/MRI与双参数MRI在检测前列腺癌方面的诊断价值比较
Prostate Int. 2022 Jun;10(2):108-116. doi: 10.1016/j.prnil.2022.03.003. Epub 2022 Mar 28.
9
SUVmax/ADC Ratio as a Molecular Imaging Biomarker for Diagnosis of Biopsy-Naïve Primary Prostate Cancer.SUVmax/ADC比值作为未经活检的原发性前列腺癌诊断的分子影像生物标志物
Indian J Nucl Med. 2021 Oct-Dec;36(4):377-384. doi: 10.4103/ijnm.ijnm_62_21. Epub 2021 Dec 15.
10
Clinical value of negative Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients.PSMA Ga-68 PET/CT 在生化复发前列腺癌患者管理中的临床价值。
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):87-94. doi: 10.1007/s00259-020-04914-8. Epub 2020 Jun 26.

引用本文的文献

1
The Role of Radiomics and Artificial Intelligence Applied to Staging PSMA PET in Assessing Prostate Cancer Aggressiveness.放射组学和人工智能在前列腺特异性膜抗原正电子发射断层显像分期评估前列腺癌侵袭性中的作用
J Clin Med. 2025 May 9;14(10):3318. doi: 10.3390/jcm14103318.
2
Multimodal radiomics based on fluorine-18 prostate-specific membrane antigen positron emission tomography and multiparametric magnetic resonance imaging in predicting persistent prostate-specific antigen after radical prostatectomy.基于氟-18前列腺特异性膜抗原正电子发射断层扫描和多参数磁共振成像的多模态放射组学在预测前列腺癌根治术后前列腺特异性抗原持续存在中的应用
Quant Imaging Med Surg. 2025 Apr 1;15(4):3176-3188. doi: 10.21037/qims-24-2162. Epub 2025 Mar 28.
3

本文引用的文献

1
Multiparametric MRI and Radiomics in Prostate Cancer: A Review of the Current Literature.多参数磁共振成像与放射组学在前列腺癌中的应用:当前文献综述
Diagnostics (Basel). 2021 Oct 3;11(10):1829. doi: 10.3390/diagnostics11101829.
2
Diagnostic Performance of Ga Prostate-specific Membrane Antigen PET/MRI Compared with Multiparametric MRI for Detecting Clinically Significant Prostate Cancer.镓前列腺特异性膜抗原 PET/MRI 与多参数 MRI 检测临床显著前列腺癌的诊断性能比较。
Radiology. 2021 Nov;301(2):379-386. doi: 10.1148/radiol.2021204093. Epub 2021 Aug 31.
3
What's behind Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns.
Enhanced ISUP grade prediction in prostate cancer using multi-center radiomics data.
利用多中心影像组学数据增强前列腺癌的ISUP分级预测
Abdom Radiol (NY). 2025 Sep;50(9):4301-4310. doi: 10.1007/s00261-025-04858-3. Epub 2025 Mar 6.
4
Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Radiomic Models in Prostate Cancer Prognostication.前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描衍生的放射组学模型在前列腺癌预后评估中的应用
Cancers (Basel). 2024 May 16;16(10):1897. doi: 10.3390/cancers16101897.
5
Robustness of magnetic resonance imaging and positron emission tomography radiomic features in prostate cancer: Impact on recurrence prediction after radiation therapy.前列腺癌中磁共振成像和正电子发射断层扫描影像组学特征的稳健性:对放射治疗后复发预测的影响。
Phys Imaging Radiat Oncol. 2023 Dec 31;29:100530. doi: 10.1016/j.phro.2023.100530. eCollection 2024 Jan.
6
PET/CT in Prostate Cancer.前列腺癌中的正电子发射断层显像/计算机断层扫描(PET/CT)
Cancers (Basel). 2023 Jul 25;15(15):3751. doi: 10.3390/cancers15153751.
7
Novel Multiparametric Magnetic Resonance Imaging-Based Deep Learning and Clinical Parameter Integration for the Prediction of Long-Term Biochemical Recurrence-Free Survival in Prostate Cancer after Radical Prostatectomy.基于新型多参数磁共振成像的深度学习与临床参数整合用于预测前列腺癌根治术后长期无生化复发生存情况
Cancers (Basel). 2023 Jun 29;15(13):3416. doi: 10.3390/cancers15133416.
8
Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy.利用PSMA PET和多参数MRI中的放射组学特征检测局限性前列腺癌以进行生物靶向放射治疗。
EJNMMI Res. 2023 Apr 26;13(1):34. doi: 10.1186/s13550-023-00984-5.
9
The role of [F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer.[F]-DCFPyL PET/MRI 影像组学在前列腺癌病理分级分组预测中的作用。
Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2167-2176. doi: 10.1007/s00259-023-06136-0. Epub 2023 Feb 21.
10
Ga-PSMA-11 PET/CT Features Extracted from Different Radiomic Zones Predict Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer.从不同影像组学区域提取的镓-PSMA-11 PET/CT特征可预测晚期前列腺癌患者对雄激素剥夺治疗的反应。
Cancers (Basel). 2022 Oct 3;14(19):4838. doi: 10.3390/cancers14194838.
Ga-PSMA-11 在原发性前列腺癌 PET 中的摄取背后是什么?对组织病理学参数和免疫组织化学 PSMA 表达模式的调查。
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):4042-4053. doi: 10.1007/s00259-021-05501-1. Epub 2021 Aug 13.
4
The added value of PSMA PET/MR radiomics for prostate cancer staging.PSMA PET/MR 放射组学在前列腺癌分期中的附加价值。
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):527-538. doi: 10.1007/s00259-021-05430-z. Epub 2021 Jul 13.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Diagnostic Accuracy of Ga-PSMA PET/CT for Initial Detection in Patients With Suspected Prostate Cancer: A Systematic Review and Meta-Analysis.Ga-PSMA PET/CT 对疑似前列腺癌患者初始检测的诊断准确性:系统评价和荟萃分析。
AJR Am J Roentgenol. 2021 Mar;216(3):599-607. doi: 10.2214/AJR.20.23912. Epub 2021 Jan 21.
7
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.MRI 靶向、系统和联合活检在前列腺癌诊断中的应用。
N Engl J Med. 2020 Mar 5;382(10):917-928. doi: 10.1056/NEJMoa1910038.
8
Prostate Specific Membrane Antigen Targeted Positron Emission Tomography of Primary Prostate Cancer: Assessing Accuracy with Whole Mount Pathology.前列腺特异性膜抗原靶向正电子发射断层扫描在原发性前列腺癌中的应用:全器官病理评估准确性。
J Urol. 2020 Jan;203(1):92-99. doi: 10.1097/JU.0000000000000501. Epub 2019 Aug 20.
9
68Ga-PSMA PET/CT: Does it predict adverse pathology findings at radical prostatectomy?68Ga-PSMA PET/CT:它能预测根治性前列腺切除术后的不良病理发现吗?
Urol Oncol. 2019 Sep;37(9):574.e19-574.e24. doi: 10.1016/j.urolonc.2019.05.015. Epub 2019 Jun 14.
10
Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis.活检时前列腺特异性膜抗原(PSMA)的表达是前列腺癌患者初诊时的独立风险分层指标。
Front Oncol. 2018 Dec 20;8:623. doi: 10.3389/fonc.2018.00623. eCollection 2018.